TTHX-1114

N/A

Report date: 2026/05/18 20:02:07

Base Information

Drug NameTTHX-1114
Drug Alias NameTTHX-1114NM-141NM141TTHX1114
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionFibroblast growth factor 1 replacements
TargetsFibroblast growth factor 1
Therapy Area/IndicationsVascular DiseasesFuchs' Endothelial DystrophyCorneal Dystrophies, Hereditary +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesFlorida State University
China Registration ClassN/A

Develop Information

Active CompaniesTrefoil Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsFuchs' Endothelial DystrophyCorneal Dystrophies, Hereditary
Inactive IndicationsVascular DiseasesCorneal Diseases

Other Information

ATC CodeN/A
Related LinksN/A